alexion pharmaceuticals

Bullish Moving Average Cross by Alexion Pharmaceuticals (ALXN)

Published on Mon, 12/17/2012 - 12:09
By Mallory Stone in Moving average crossovers, ALXN, alexion pharmaceuticals, moving crosses, nasdaq:alxn
ALXN

By Mallory Stone
mstone@fnno.com

Shares of Alexion Pharmaceuticals Receive a Boost, Up 1.8%

Published on Tue, 12/11/2012 - 11:28
By Robert Cotter in Market movers, ALXN, alexion pharmaceuticals, market movers, nasdaq:alxn
ALXN

By Robert Cotter
rcotter@fnno.com

Amarin had the Lowest Relative Performance in the Biotechnology Industry (AMRN, INFI, CLDX, ALXN, BMRN)

AMRN

By Mallory Stone
mstone@fnno.com

Alexion Pharmaceuticals Makes a Move: Down 3.3%

Published on Fri, 12/07/2012 - 13:15
By Robert Cotter in Market movers, ALXN, alexion pharmaceuticals, market movers, nasdaq:alxn
ALXN

By Robert Cotter
rcotter@fnno.com

Bearish Moving Average Cross by Alexion Pharmaceuticals (ALXN)

Published on Wed, 12/05/2012 - 12:09
By Mallory Stone in Moving average crossovers, ALXN, alexion pharmaceuticals, moving crosses, nasdaq:alxn
ALXN

By Mallory Stone
mstone@fnno.com

Shares of Amicus Therapeutics Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (FOLD, CLDX, MDVN, CPHD, ALXN)

FOLD

By Mallory Stone
mstone@fnno.com

Morgan Stanley Raised Its PT For Alexion Pharmaceuticals To $61

Published on Fri, 07/22/2011 - 11:19
By FNNO Staff in General Interest, alexion pharmaceuticals, alxn, analysis, business, finance, market, news, stock, trading, Analyst Actions

The bank sees 2012 EPS of $1.33, up from $1.26 per share, and 2013 EPS of $1.69, up from $1.65 per share.

Alexion Pharmaceuticals is currently above its 50-day moving average (MA) of $47.96 and above its 200-day of $43.91.

alexion pharmaceuticals, alxn, analysis, business, finance, market, news, stock, trading

Morgan Stanley raised its price target for Alexion Pharmaceuticals (NASDAQ:ALXN) to $61 from $56 and maintained its overweight rating on the stock.

By FNNO Staff
fnnonline@gmail.com

Alexion Pharmaceuticals Topped Q2 Estimates, Top Line Up 47.6% YoY

The company sees 2011 EPS of $1.10 to $1.15, up from a previous range of $1.05 to $1.12 per share, vs. consensus estimates of $1.14 per share, on revenues of $745 to $755 million, up from a previous range of $720 to $740 million,

alexion pharmaceuticals, business, earnings, eps, finance, investing, market, news, revenue, second quarter, stock, trading

Alexion Pharmaceuticals (NASDAQ:ALXN) reported Q2 EPS of $0.29, ahead of consensus estimates of $0.26 per share. Revenues rose 47.6% year-over-year to $185.7 million, topping consensus estimates of $178.0 million.

By FNNO Staff
fnnonline@gmail.com

Alexion Pharmaceuticals Up 3.8% Since Citigroup Downgraded One Week Ago

Published on Fri, 02/18/2011 - 11:12
By FNNO Staff in General Interest, alexion pharmaceuticals, alxn, analysis, business, financial, market, news, stock, trading, Analyst Insight

Alexion Pharmaceuticals has overhead space with shares priced $94.28, or 1.2% below the average consensus analyst price target of $95.44. Alexion Pharmaceuticals shares have support at the 50-day moving average (MA) of $83.45 and

alexion pharmaceuticals, alxn, analysis, business, financial, market, news, stock, trading

A week ago, Citigroup downgraded Alexion Pharmaceuticals (ALXN) from Buy to Hold. Alexion Pharmaceuticals stocks closed at $93.37, a 3.8% gain over the course of one week.

By FNNO Staff
fnnonline@gmail.com

Sector Update: Health Care - January 31, 2011

alexion pharmaceuticals, alxn, business, genz, genzyme, healthcare, higher, income, investment, market, news, sanofi-aventis, sector, shares, sny, stocks, taligen therapeutics, trade, update

Health care shares are higher in mid-session trading as acquisition talks between Genzyme (GENZ) and Sanofi-Aventis (SNY) take a step forward. discussions with Sanofi are said to have progressed to the point where Genzyme's board

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News